The announcement of a contract with DARPA, a prominent agency known for funding advanced research projects, is a significant positive development for Ginko Bioworks. This contract not only provides financial benefits but also enhances the company's credibility and visibility in the biotech and defense sectors. Such announcements typically lead to increased investor confidence and can drive the stock price up in the short term.